IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
-9.51%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$486M
AUM Growth
+$486M
(+27%)
Cap. Flow
+$142M
Cap. Flow
% of AUM
29.12%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
86
New
15
Increased
40
Reduced
9
Closed
21
Top Buys
| 1 |
Eli Lilly
LLY
|
$23.7M |
| 2 |
Sanofi
SNY
|
$17.5M |
| 3 |
Centene
CNC
|
$16.9M |
| 4 |
McKesson
MCK
|
$13.6M |
| 5 |
DexCom
DXCM
|
$12.4M |
Top Sells
| 1 |
Pfizer
PFE
|
$15.5M |
| 2 |
Globus Medical
GMED
|
$13.3M |
| 3 |
Acadia Healthcare
ACHC
|
$9.83M |
| 4 |
AMED
Amedisys
AMED
|
$6.89M |
| 5 |
Cigna
CI
|
$5.99M |
Sector Composition
| 1 | Healthcare | 97.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Inspire Medical Systems
INSP
$2.53B
| – | – |
-10,000
| Closed | -$2.57M |
|
77
Incyte
INCY
$17B
| – | – |
-18,000
| Closed | -$1.43M |
|
|
78
Globus Medical
GMED
$7.94B
| – | – |
-180,000
| Closed | -$13.3M |
|
79
Precision BioSciences
DTIL
$59.5M
| – | – |
-350,000
| Closed | -$1.08M |
|
80
Doximity
DOCS
$12.6B
| – | – |
-30,000
| Closed | -$1.56M |
|
81
Denali Therapeutics
DNLI
$2.24B
| – | – |
-26,000
| Closed | -$836K |
|
|
82
Cigna
CI
$80.2B
| – | – |
-25,000
| Closed | -$5.99M |
|
83
Biogen
BIIB
$20.8B
| – | – |
-15,000
| Closed | -$3.16M |
|
84
Avalo Therapeutics
AVTX
$139M
| – | – |
-700,000
| Closed | -$507K |
|
|
AMED
85
DELISTED
Amedisys
AMED
| – | – |
-40,000
| Closed | -$6.89M |
|
|
86
Acadia Healthcare
ACHC
$2.15B
| – | – |
-150,000
| Closed | -$9.83M |
|